|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin M, Shi C, Lin X, Pan J, Shen S, Xu Z
and Chen Q: sMicroRNA-1290 inhibits cells proliferation and
migration by targeting FOXA1 in gastric cancer cells. Gene.
582:137–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayes EL and Lewis-Wambi JS: Mechanisms of
endocrine resistance in breast cancer: An overview of the proposed
roles of noncoding RNA. Breast Cancer Res. 17:402015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun Y, Luo ZM, Guo XM, Su DF and Liu X: An
updated role of microRNA-124 in central nervous system disorders: A
review. Front Cell Neurosci. 9:1932015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng T, Shao F, Wu Q, Zhang X, Xu D, Qian
K, Xie Y, Wang S, Xu N, Wang Y and Qi C: miR-124 downregulation
leads to breast cancer progression via LncRNA-MALAT1 regulation and
CDK4/E2F1 signal activation. Oncotarget. 7:16205–16216.
2016.PubMed/NCBI
|
|
7
|
Shi XB, Ma AH, Xue L, Li M, Nguyen HG,
Yang JC, Tepper CG, Gandour-Edwards R, Evans CP, Kung HJ, et al:
miR-124 and androgen receptor signaling inhibitors repress prostate
cancer growth by downregulating androgen receptor splice variants,
EZH2 and Src. Cancer Res. 75:5309–5317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zu L, Xue Y and Wang J, Fu Y, Wang X, Xiao
G, Hao M, Sun X, Wang Y, Fu G and Wang J: The feedback loop between
miR-124 and TGF-β pathway plays a significant role in non-small
cell lung cancer metastasis. Carcinogenesis. 37:333–343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Liu S, Tian L, Wu M, Ai F, Tang W,
Zhao L, Ding J, Zhang L and Tang A: miR-124 and miR-506 inhibit
colorectal cancer progression by targeting DNMT3B and DNMT1.
Oncotarget. 6:38139–38150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie
Y, Li S, Tang G, Tang H and He X: MicroRNA-124 inhibits
proliferation and induces apoptosis by directly repressing EZH2 in
gastric cancer. Mol Cell Biochem. 392:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through down-regulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu L, Ye JX, Qin YZ, Chen QH and Ge LY:
Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting
lymph node metastasis and tumor stage of gastric cancer. Int J Clin
Exp Med. 8:22227–22236. 2015.PubMed/NCBI
|
|
15
|
Jiang L, Lai YK, Zhang J, Wang H, Lin MC,
He ML and Kung HF: Targeting S100P inhibits colon cancer growth and
metastasis by Lentivirus-mediated RNA interference and proteomic
analysis. Mol Med. 17:709–716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Lin MC, Wang H, Chan CY, Jiang L,
Ngai SM, Yu J, He ML, Shaw PC, Yew DT, et al: Proteomic analysis of
EZH2 downstream target proteins in hepatocellular carcinoma.
Proteomics. 7:3097–3104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Steg AD, Katre AA, Goodman B, Han HD, Nick
AM, Stone RL, Coleman RL, Alvarez RD, Lopez-Berestein G, Sood AK
and Landen CN: Targeting the notch ligand JAGGED1 in both tumor
cells and stroma in ovarian cancer. Clin Cancer Res. 17:5674–5685.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang P, Chen L, Zhang J, Chen H, Fan J,
Wang K, Luo J, Chen Z, Meng Z and Liu L: Methylation-mediated
silencing of the miR-124 genes facilitates pancreatic cancer
progression and metastasis by targeting Rac1. Oncogene. 33:514–524.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saito Y: Alterations of epigenetics and
microRNAs in cancer and cancer stem cell. Front Genet. 5:2832014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang N, Huang Y, Wu F, Zhao Y, Li X, Shen
P, Yang L, Luo Y, Yang L and He G: Codelivery of a miR-124 mimic
and obatoclax by cholesterol-penetratin micelles simultaneously
induces apoptosis and inhibits autophagic flux in breast cancer in
vitro and in vivo. Mol Phar. 13:2466–2483. 2016. View Article : Google Scholar
|
|
26
|
Feng T, Xu D, Tu C, Li W, Ning Y, Ding J,
Wang S, Yuan L, Xu N, Qian K, et al: MiR-124 inhibits cell
proliferation in breast cancer through downregulation of CDK4.
Tumour Biol. 36:5987–5997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang W, Mao YQ, Wang H, Yin WJ, Zhu SX
and Wang WC: MiR-124 suppresses cell motility and adhesion by
targeting talin 1 in prostate cancer cells. Cancer Cell Int.
15:492015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun Y, Ai X, Shen S and Lu S:
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung
cancer by targeting MYO10. Oncotarget. 6:8244–8254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
